These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 24075740)
1. Long-term use of statins reduces the risk of hospitalization for dementia. Corrao G; Ibrahim B; Nicotra F; Zambon A; Merlino L; Pasini TS; Catapano AL; Mancia G Atherosclerosis; 2013 Oct; 230(2):171-6. PubMed ID: 24075740 [TBL] [Abstract][Full Text] [Related]
2. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice. Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658 [TBL] [Abstract][Full Text] [Related]
3. Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care. Harley CR; Gandhi SK; Heien H; McDonough K; Nelson SP Expert Opin Pharmacother; 2008 Apr; 9(5):669-76. PubMed ID: 18345946 [TBL] [Abstract][Full Text] [Related]
4. Differences between statins on clinical endpoints: a population-based cohort study. Dieleman JP; van Wyk JT; van Wijk MA; van Herpen G; Straus SM; Dunselman H; Sturkenboom MC Curr Med Res Opin; 2005 Sep; 21(9):1461-8. PubMed ID: 16197665 [TBL] [Abstract][Full Text] [Related]
5. The use over time of statins in coronary patients in an Italian tertiary referral center. Gaspardone A; Proietti I; Altamura L; Tomai F; Versaci F; Crea F; Chiariello L; Gioffrè PA Ital Heart J; 2001 Nov; 2(11):848-53. PubMed ID: 11770871 [TBL] [Abstract][Full Text] [Related]
7. Effects of switching statins on achievement of lipid goals: Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) study. Schuster H; Barter PJ; Stender S; Cheung RC; Bonnet J; Morrell JM; Watkins C; Kallend D; Raza A; Am Heart J; 2004 Apr; 147(4):705-13. PubMed ID: 15077101 [TBL] [Abstract][Full Text] [Related]
8. Use of an indirect effect model to describe the LDL cholesterol-lowering effect by statins in hypercholesterolaemic patients. Faltaos DW; Urien S; Carreau V; Chauvenet M; Hulot JS; Giral P; Bruckert E; Lechat P Fundam Clin Pharmacol; 2006 Jun; 20(3):321-30. PubMed ID: 16671968 [TBL] [Abstract][Full Text] [Related]
9. Time-dependent effect of statins on platelet function in hypercholesterolaemia. Puccetti L; Pasqui AL; Pastorelli M; Bova G; Cercignani M; Palazzuoli A; Angori P; Auteri A; Bruni F Eur J Clin Invest; 2002 Dec; 32(12):901-8. PubMed ID: 12534449 [TBL] [Abstract][Full Text] [Related]
10. Good adherence to therapy with statins reduces the risk of adverse clinical outcomes even among very elderly. Evidence from an Italian real-life investigation. Corrao G; Monzio Compagnoni M; Franchi M; Cantarutti A; Pugni P; Merlino L; Catapano AL; Mancia G Eur J Intern Med; 2018 Jan; 47():25-31. PubMed ID: 28958460 [TBL] [Abstract][Full Text] [Related]
11. Fluvastatin as co-medication in heart transplant recipients with elevated creatine-kinase. Sadoni S; Kaczmarek I; Delgado O; Schmöckel M; Reichart B; Meiser B Transplant Proc; 2007 Mar; 39(2):558-9. PubMed ID: 17362781 [TBL] [Abstract][Full Text] [Related]
12. Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention. Zhou Z; Rahme E; Pilote L Am Heart J; 2006 Feb; 151(2):273-81. PubMed ID: 16442888 [TBL] [Abstract][Full Text] [Related]
13. Which statin is most efficient for the treatment of hypercholesterolemia? A cost-effectiveness analysis. Cobos A; Jovell AJ; García-Altés A; García-Closas R; Serra-Majem L Clin Ther; 1999 Nov; 21(11):1924-36. PubMed ID: 10890264 [TBL] [Abstract][Full Text] [Related]
14. A cost-effectiveness model of alternative statins to achieve target LDL-cholesterol levels. Maclaine GD; Patel H Int J Clin Pract; 2001 May; 55(4):243-9. PubMed ID: 11406909 [TBL] [Abstract][Full Text] [Related]
15. Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease. Wolozin B; Wang SW; Li NC; Lee A; Lee TA; Kazis LE BMC Med; 2007 Jul; 5():20. PubMed ID: 17640385 [TBL] [Abstract][Full Text] [Related]
16. Variable influence of statins on isoprostanes in hyperlipidemia. Sinzinger H; Oguogho A Adv Exp Med Biol; 2003; 525():209-12. PubMed ID: 12751770 [No Abstract] [Full Text] [Related]
17. Update on statins. Mason P J Vasc Nurs; 2004 Jun; 22(2):49-50. PubMed ID: 15179417 [No Abstract] [Full Text] [Related]
18. Persistence and adherence to cholesterol lowering agents: evidence from Régie de l'Assurance Maladie du Québec data. Lachaine J; Rinfret S; Merikle EP; Tarride JE Am Heart J; 2006 Jul; 152(1):164-9. PubMed ID: 16824851 [TBL] [Abstract][Full Text] [Related]
19. Effects of switching statins on lipid and apolipoprotein ratios in the MERCURY I study. Cheung RC; Morrell JM; Kallend D; Watkins C; Schuster H Int J Cardiol; 2005 Apr; 100(2):309-16. PubMed ID: 15823640 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness of statins for secondary prevention in elderly patients after acute myocardial infarction: an evaluation of class effect. Zhou Z; Rahme E; Abrahamowicz M; Tu JV; Eisenberg MJ; Humphries K; Austin PC; Pilote L CMAJ; 2005 Apr; 172(9):1187-94. PubMed ID: 15851712 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]